NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries Life Science Investing
Right Season Investments Engages MCS Market Communication Service to Provide Market Support Psychedelics Investing
Cizzle Brands Corporation Releases its Fiscal Q4 2025 and Full Year 2025 Results; Achieves 92% Revenue Growth over Prior Year Q4 on Accelerating Brand Expansion Biotech Investing
The One & Only BOTOX® Cosmetic Day Returns November 19 with the Biggest Celebration of the Year Pharmaceutical Investing
Guardant Health Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance Life Science Investing
argenx Presents New Data at AANEM and MGFA Highlighting the Strength and Broad Benefit of VYVGART for Myasthenia Gravis Patients Biotech Investing
Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis® Manufacturing Platform for Therapeutic siRNA Manufacturing Life Science Investing
